Allinaire Therapeutics

About:

Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.

Website: http://www.allinaire.com

Top Investors: BioCrossroads, BioMotiv, IU Ventures

Description:

Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. The technology is based on the discovery by scientific founders Irina Petrache, MD, and Matthias Clauss, Ph.D. of a novel therapeutic target that plays a central role in the development and progression of lung disease.

Total Funding Amount:

$1.57M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cleveland, Ohio, United States

Founded Date:

2016-01-01

Contact Email:

eberezovsky(AT)biomotiv.com

Founders:

Irina Petrache, Matthias Clauss, Wade Lange

Number of Employees:

11-50

Last Funding Date:

2017-01-27

IPO Status:

Private

Industries: